Blueprints for the rational design of therapeutic mutacin 1140 variants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blueprints for the rational design of therapeutic mutacin 1140 variants

Published:2018-08-18 Issue:6 Volume:92 Page:1940-1953
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Kers Johan A.¹,Sharp R. Eryl¹,Muley Sheela¹,Mayo Melissa¹,Colbeck Jeffrey¹,Zhu Yihui¹,DeFusco Anthony W.²,Park Jae H.²,Handfield Martin²^ORCID

Affiliation:

1. Intrexon Corp.; Industrial Products Division; South San Francisco California

2. Oragenics, Inc.; Alachua Florida

Funder

Oragenics, Inc

Intrexon Corp

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cbdd.13365/fullpdf

Reference45 articles.

1. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

2. Biosynthesis and Mode of Action of Lantibiotics

3. Fundamental functionality: recent developments in understanding the structure–activity relationships of lantibiotic peptides

4. Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics

5. Bioengineering of the model lantibiotic nisin

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteriocin diversity, function, discovery and application as antimicrobials;Nature Reviews Microbiology;2024-05-10

2. Natural products from the human microbiome: an emergent frontier in organic synthesis and drug discovery;Organic & Biomolecular Chemistry;2024

3. Methods for identification of the modes of action of lantibiotics;Lantibiotics as Alternative Therapeutics;2023

4. Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties;Microbiology Spectrum;2022-12-21

5. Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics;European Journal of Pharmaceutics and Biopharmaceutics;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3